Vistusertib (AZD2014) Monotherapy in Relapsed Small Cell Lung Cancer Patients Harboring RICTOR Amplification
Clinical trial NCT03106155 · TERMINATED
Trial details
- NCT number
- NCT03106155
- Sponsor
- Samsung Medical Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-02
- Primary completion
- 2018-05-03
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.